We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Oxford Biodynamics Plc | LSE:OBD | London | Ordinary Share | GB00BD5H8572 | ORD GBP0.01 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.27 | -3.33% | 7.85 | 7.80 | 7.90 | 8.02 | 7.90 | 8.02 | 409,301 | 16:35:24 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Biological Pds,ex Diagnstics | 1.34M | -10.83M | -0.0535 | -1.48 | 15.98M |
From May 2019 to May 2024
TIDMOBD
RNS Number : 9027K
Oxford BioDynamics PLC
02 September 2019
2 September 2019
Oxford BioDynamics Plc
("OBD" or the "Company" and, together with its subsidiaries, the "Group")
PDMR Dealing
Oxford BioDynamics Plc (AIM: OBD) announces that today it received notification that Vulpes Life Sciences Find, which is controlled by Non-Executive Director Stephen Diggle, Christian Hoyer Millar, Chief Executive Officer, and Paul Stockdale, Chief Financial Officer, have purchased Ordinary Shares of 1 pence each as follows:
Hot Features
Premium
Name Number of shares purchased Average price per
share
Vulpes Life Sciences 6,730 GBP0.9200
Fund
--------------------------- ------------------
Christian Hoyer Millar 14,000 GBP0.8551
--------------------------- ------------------
Paul Stockdale 2,186 GBP0.9125
--------------------------- ------------------
Following these transactions, Vulpes Life Sciences Fund, Christian Hoyer Millar (together with his wife) and Paul Stockdale are respectively interested in the Ordinary Shares of the Company as follows:
Name Number of Ordinary % of issued share
Shares held capital
Vulpes Life Sciences
Fund 11,741,455 12.69
------------------- ------------------
Christian Hoyer Millar 12,354,303 13.35
------------------- ------------------
Paul Stockdale 10,000 0.01
------------------- ------------------
The notifications below, made in accordance with the requirements of the EU Market Abuse Regulation, provide further details:
1 Details of the person discharging managerial responsibilities/person
closely associated
a) Name Stephen Diggle
------------------------------- --------------------------------------
2 Reason for the notification
-----------------------------------------------------------------------
a) Position/status Director/PDMR
------------------------------- --------------------------------------
b) Initial notification/ Initial notification
Amendment
------------------------------- --------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-----------------------------------------------------------------------
a) Name Oxford BioDynamics Plc
------------------------------- --------------------------------------
b) LEI 2138005Y1TK258O5U928
------------------------------- --------------------------------------
4 Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii)
each date; and (iv) each place where transactions have been
conducted
-----------------------------------------------------------------------
a) Description of the Ordinary Shares of 1 pence each
financial instrument, ISIN: GB00BD5H8572
type of instrument
Identification code
------------------------------- --------------------------------------
b) Nature of the transaction Acquisition of ordinary shares
------------------------------- --------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
GBP0.92 6,730
----------
------------------------------- --------------------------------------
d) Aggregated information Price Volume
- Aggregated volume GBP0.92 6,730
- Price -------
------------------------------- --------------------------------------
e) Dates of the transactions 30 August 2019
------------------------------- --------------------------------------
f) Place of the transaction Outside a trading venue
------------------------------- --------------------------------------
1 Details of the person discharging managerial responsibilities/person
closely associated
a) Name Christian Hoyer Millar
------------------------------- --------------------------------------
2 Reason for the notification
-----------------------------------------------------------------------
a) Position/status Director/PDMR
------------------------------- --------------------------------------
b) Initial notification/ Initial notification
Amendment
------------------------------- --------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-----------------------------------------------------------------------
a) Name Oxford BioDynamics Plc
------------------------------- --------------------------------------
b) LEI 2138005Y1TK258O5U928
------------------------------- --------------------------------------
4 Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii)
each date; and (iv) each place where transactions have been
conducted
-----------------------------------------------------------------------
a) Description of the Ordinary Shares of 1 pence each
financial instrument, ISIN: GB00BD5H8572
type of instrument
Identification code
------------------------------- --------------------------------------
b) Nature of the transaction Acquisition of ordinary shares
------------------------------- --------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
GBP0.85135 4,000
----------
GBP0.85 4,000
----------
GBP0.85135 2,000
----------
GBP0.8658 4,000
----------
------------------------------- --------------------------------------
d) Aggregated information Price Volume
- Aggregated volume GBP0.8551 14,000
- Price -------
------------------------------- --------------------------------------
e) Dates of the transactions 30 August 2019
------------------------------- --------------------------------------
f) Place of the transaction Outside a trading venue
------------------------------- --------------------------------------
1 Details of the person discharging managerial responsibilities/person
closely associated
a) Name Paul Stockdale
------------------------------- --------------------------------------
2 Reason for the notification
-----------------------------------------------------------------------
a) Position/status Director/PDMR
------------------------------- --------------------------------------
b) Initial notification/ Initial notification
Amendment
------------------------------- --------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-----------------------------------------------------------------------
a) Name Oxford BioDynamics Plc
------------------------------- --------------------------------------
b) LEI 2138005Y1TK258O5U928
------------------------------- --------------------------------------
4 Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii)
each date; and (iv) each place where transactions have been
conducted
-----------------------------------------------------------------------
a) Description of the Ordinary Shares of 1 pence each
financial instrument, ISIN: GB00BD5H8572
type of instrument
Identification code
------------------------------- --------------------------------------
b) Nature of the transaction Acquisition of ordinary shares
------------------------------- --------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
GBP0.9125 2,186
----------
------------------------------- --------------------------------------
d) Aggregated information Price Volume
- Aggregated volume GBP0.9125 2,186
- Price -------
------------------------------- --------------------------------------
e) Date of the transaction 30 August 2019
------------------------------- --------------------------------------
f) Place of the transaction Outside a trading venue
------------------------------- --------------------------------------
For further details please contact:
Oxford BioDynamics Plc Christian Hoyer Millar, CEO Paul Stockdale, CFO +44 (0)1865 518910 Shore Capital Nominated Adviser and Broker Stephane Auton Edward Mansfield +44 (0)20 7408 4090 FTI Consulting Financial Public Relations Adviser Brett Pollard Natalie Garland-Collins +44 (0)20 3727 1000
Notes for Editors
About Oxford BioDynamics Plc
Oxford BioDynamics Plc (AIM: OBD) ("Oxford BioDynamics") is a biotechnology company focused on the discovery and development of epigenetic biomarkers for use within the pharmaceutical and biotechnology industry.
The Company's award-winning, proprietary technology platform, EpiSwitch(TM), aims to accelerate the drug discovery and development process, improve the success rate of therapeutic product development and take advantage of the increasing importance of personalised medicine.
In particular, EpiSwitch(TM) can reduce time to market, failure rates and the costs at every stage of drug discovery. Additionally, the technology provides significant insights into disease mechanisms for drug discovery and product re--positioning programmes and enables the personalisation of therapeutics for patients in the context of challenging pricing environments where improved clinical outcomes are critical.
In April 2019, Oxford BioDynamics received the Queen's Award for Enterprise: Innovation. The Queen's Awards for Enterprise are the most prestigious awards for UK businesses.
Oxford BioDynamics is headquartered in the UK, and listed on the London Stock Exchange's AIM under the ticker "OBD". For more information please visit www.oxfordbiodynamics.com.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
DSHLTMMTMBBMBRL
(END) Dow Jones Newswires
September 02, 2019 06:18 ET (10:18 GMT)
1 Year Oxford Biodynamics Chart |
1 Month Oxford Biodynamics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
